| 中文名称 | 恩曲他滨 |
|---|---|
| 中文别名 | 恩曲他滨;5-氟-1-(2R,5S)-[2-羟甲基-1,3-氧硫环-5-酰]胞嘧啶;依曲西他滨;Emtricitabine 恩曲他滨;S-马尼地平;恩曲他滨 USP标准品;恩曲他滨 标准品;恩曲他滨杂质;恩曲他滨中间体;富马酸亚铁;茚曲他滨;盐酸恩曲他滨 |
| 英文名称 | Emtricitabine |
| 英文别名 | 4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-(2r-cis)-2(1h)-pyrimidinone;(-)-BETA-2',3'-DIDEOXY-5-FLUORO-3'-THIACYTIDINE;EMTRITABINE;FTC;FUMITREMORGIN C;SM-Q;EMTRICITABIN;4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone,(-)-FTC,(-)-b-23Dideoxy-5-flu;4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone, (-)-FTC, (-)-b-23Dideoxy-5-fluoro-3thiacytidine, 524W91, BW-52491, Coviracil,;Entricitabine;2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl-;2'-deoxy-5-fluoro-3'-thiacytidine;4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone, (-)-FTC, (-)--2’,3’-Dideoxy-5-fluoro-3’-thiacytidine, 524W91, BW-52491, Coviracil;BW1592;Emtricitabine;BW-1592;(−)-2′3′-Dideoxy-5-fluoro-3′-thiacytidine;(2R,5S)-4-Amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one;Emtricitabine [USAN:INN];Coviracil;Emtricitabine- Bio-X;Emtriva;EMTRICITABINE [WHO-DD];DRG-0208;SMR002533604;4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone;BDBM50107843;D01199;Tox21_112193;NCGC00164564-01;524-W-91;G70B4ETF4S;Emtricitabine?;(+/-)-FTC;Emtriva(TM);CHEMBL885;W-201247;NCGC00164564-10;2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, rel-;Ftc, dl-;D72669;EMTRICITABINE [HSDB];BE165946;BRD-K61452026-001-04-6;4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one;NSC-804863;4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-;C8H10FN3O3S;EMTRICITABINE [WHO-IP];Z1521553474;Q422604;EMTRICITABINUM [WHO-IP LATIN];(-)-.beta.-L-FTC;E1007;W-201248;Emtricitabine, (+/-)-;Emtricitabine (1.0 mg/mL in Methanol);Coviracil(TM);TRUVADA COMPONENT EMTRICITABINE;CCG-220615;BW524W91;5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine;NCGC00164564-06;UNII-G70B4ETF4S;PSI 5004;2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, cis-(+-)-;NSC804863;EMTRICITABINE [EMA EPAR];EMTRICITABINE [USAN];2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-;EMTRICITABINE [VANDF];2',3',5-FTC;143491-54-7;STRIBILD COMPONENT EMTRICITABINE;CHEBI:31536;EMTRICITABINE [JAN];rel-4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone;EN300-119501;AS-14099;MLS003882429;145213-48-5;EX-A150;EMTRICITABINE [USP-RS];ULS8902U4O;(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine;(-)-2'-Deoxy-5-fluoro-3'-thiacytidine;GTPL11244;Emtricitabine, (-)-;Emtricitabine 100 microg/mL in Acetonitrile;2(1H)-Pyrimidinone,4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,... |
| CAS No. | 143491-57-0 |
| 分子式 | C8H10FN3O3S |
| 分子量 | 247.25 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学